Concepedia

Brian Sherer

BS

Statistics

Publications

14

Citations

775

H-Index

13

Active since

2001

Affiliations

AstraZeneca (United States)(Current)

Ono Pharmaceutical (United States)

Merck Serono S.p.A. (Italy)

Research & Development Institute

Merck KGaA, Darmstadt (Germany)

Brian Sherer is an author at AstraZeneca (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2001–2023

14

Publications

14

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Richard D. Caldwell, Hui Qiu, Ben Askew et al. · Journal of Medicinal Chemistry · 2019 · 140 citations · Full text

, , +14

Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial Agents

Ann E. Eakin, Oluyinka Green, Neil J. Hales et al. · Antimicrobial Agents and Chemotherapy · 2011 · 134 citations

, , +17

Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy

Brian Sherer, Kenneth G. Hull, Oluyinka Green et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 121 citations · Full text

, , +14

Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity

Jaromir Vlach, Andrew T. Bender, Melinda Przetak et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 86 citations · Full text

, , +15

Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099)

Gregory S. Basarab, Pamela Hill, C. Edwin Garner et al. · Journal of Medicinal Chemistry · 2014 · 81 citations · Full text

, , +17

1–5 of 14